Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 06/30/14
Due: 06/30/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate | NCT02402283 | Verisfield UK Ltd. Greek Branch | user2@example.com | None | 2015-05-31 | 2015-05-31 | 2016-05-31 | - | - | 2025-07-14 |
| Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet) | NCT02767310 | Verisfield UK Ltd. Greek Branch | user2@example.com | None | 2016-05-31 | 2016-06-30 | 2017-06-30 | - | - | 2025-07-14 |
| Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. | NCT02146209 | Verisfield UK Ltd. Greek Branch | user2@example.com | None | 2014-06-30 | 2014-06-30 | 2015-06-30 | - | - | 2025-07-14 |